In clinical trials, the expansion and persistence of CAR-T cells correlate with therapeutic efficacy. However, properties of CAR-T cells that enable their in vivo proliferation have still to be consistently defined and the role of CAR-T bag content has never been investigated in a real life setting.

Phenotypic composition of commercial anti-CD19 CAR-T cells affects in vivo expansion and disease response in large B-cell lymphoma patients / C. Monfrini, F. Stella, V. Aragona, M. Magni, S. Ljevar, C. Vella, E. Fardella, A. Chiappella, F. Nanetti, M. Pennisi, A. Dodero, A. Guidetti, P. Corradini, C. Carniti. - In: CLINICAL CANCER RESEARCH. - ISSN 1078-0432. - 28:15(2022 May 18), pp. 3378-3386. [10.1158/1078-0432.CCR-22-0164]

Phenotypic composition of commercial anti-CD19 CAR-T cells affects in vivo expansion and disease response in large B-cell lymphoma patients

F. Stella
Secondo
;
M. Magni;E. Fardella;M. Pennisi;A. Guidetti;P. Corradini
;
2022

Abstract

In clinical trials, the expansion and persistence of CAR-T cells correlate with therapeutic efficacy. However, properties of CAR-T cells that enable their in vivo proliferation have still to be consistently defined and the role of CAR-T bag content has never been investigated in a real life setting.
Settore MED/15 - Malattie del Sangue
Article (author)
File in questo prodotto:
File Dimensione Formato  
3378.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 874.98 kB
Formato Adobe PDF
874.98 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/934534
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 2
social impact